Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
"Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C (TRIUMPH-2, TRIUMPH-3)." Investor Relations
Even though your diet should provide these, its difficult to guarantee regular intake of all the necessary nutrients
What the research shows about tirzepatide and lean mass A systematic review published in 2025 examining tirzepatide effects on skeletal muscle mass found that lean tissue loss accounts for 20% to 34% of total weight lost during treatment
Alzheimers Dement (2020) 16(9):131229
For overweight/obesity patients, the rate was 6.7% with semaglutide compared to 0.8% with other weight-loss medications
The total peptide content is listed on the product label
